Delirium in COVID-19 patients: a multicentric observational study in Italy

[1]  F. Nobili,et al.  Is the Frontal Lobe the Primary Target of SARS-CoV-2? , 2021, Journal of Alzheimer's disease : JAD.

[2]  E. Figueroa,et al.  Early use of corticosteroids in non-critical patients with COVID-19 pneumonia (PREDCOVID): a structured summary of a study protocol for a randomised controlled trial , 2021, Trials.

[3]  Sara C. LaHue,et al.  Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): a multicentre cohort study , 2021, The Lancet Respiratory Medicine.

[4]  B. Wei,et al.  Risk factors for emergence agitation in adults after general anesthesia: A systematic review and meta‐analysis , 2020, Acta anaesthesiologica Scandinavica.

[5]  D. Sodickson,et al.  The brain after COVID-19: Compensatory neurogenesis or persistent neuroinflammation? , 2020, EClinicalMedicine.

[6]  H. Ulrich,et al.  Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology , 2020, Molecular Psychiatry.

[7]  M. Onofrj,et al.  Low molecular weight heparin in COVID-19 patients prevents delirium and shortens hospitalization , 2020, Neurological Sciences.

[8]  M. Onofrj,et al.  New-onset refractory status epilepticus (NORSE) in post SARS-CoV-2 autoimmune encephalitis: a case report , 2020, Neurological Sciences.

[9]  M. Onofrj,et al.  Diaphragmatic myoclonus due to SARS-CoV-2 infection , 2020, Neurological Sciences.

[10]  C. Barbui,et al.  Safety of psychotropic medications in people with COVID-19 , 2020, European Psychiatry.

[11]  A. Fagiolini,et al.  Psychomotor agitation and hyperactive delirium in COVID-19 patients treated with aripiprazole 9.75 mg/1.3 ml immediate release , 2020, Psychopharmacology.

[12]  L. Fratiglioni,et al.  The impact of delirium on outcomes for older adults hospitalised with COVID-19 , 2020, Age and ageing.

[13]  S. Kremer,et al.  Delirium and encephalopathy in severe COVID-19: a cohort analysis of ICU patients , 2020, Critical Care.

[14]  R. Thangavel,et al.  COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation , 2020, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[15]  R. Emsley,et al.  Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations , 2020, BMC Medicine.

[16]  J. Labrador,et al.  Outpatient treatment of COVID-19 with steroids in the phase of mild pneumonia without the need for admission as an opportunity to modify the course of the disease: A structured summary of a randomised controlled trial , 2020, Trials.

[17]  A. Fagiolini,et al.  Pharmacological treatment of hyperactive delirium in people with COVID-19: rethinking conventional approaches , 2020, Therapeutic advances in psychopharmacology.

[18]  H. Krumholz,et al.  Extrapulmonary manifestations of COVID-19 , 2020, Nature Medicine.

[19]  R. Garg,et al.  Encephalopathy in patients with COVID‐19: A review , 2020, Journal of medical virology.

[20]  A. Qureshi,et al.  Major Neurologic Adverse Drug Reactions, Potential Drug–Drug Interactions and Pharmacokinetic Aspects of Drugs Used in COVID-19 Patients with Stroke: A Narrative Review , 2020, Therapeutics and clinical risk management.

[21]  R. José,et al.  COVID-19 cytokine storm: the interplay between inflammation and coagulation , 2020, The Lancet Respiratory Medicine.

[22]  J. Sejvar,et al.  Neurological associations of COVID-19 , 2020, The Lancet Neurology.

[23]  Sara C. LaHue,et al.  Collaborative Delirium Prevention in the Age of COVID‐19 , 2020, Journal of the American Geriatrics Society.

[24]  P. Mazzanti,et al.  Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia. , 2020, Journal of the American Medical Directors Association.

[25]  Russell B. Fletcher,et al.  Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia , 2020, Science Advances.

[26]  J. Xiang,et al.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.

[27]  Z. Peng,et al.  Intensive care during the coronavirus epidemic , 2020, Intensive Care Medicine.

[28]  J. Albert,et al.  Fatal encephalitis associated with coronavirus OC43 in an immunocompromised child , 2020, Infectious diseases.

[29]  Alain Le Coupanec,et al.  Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System? , 2019, Viruses.

[30]  Natasha Keric,et al.  Delirium as a Predictor of Mortality in Mechanically Ventilated Patients in the Intensive Care Unit , 2019, 50 Landmark Papers.

[31]  Hongxin Dong,et al.  The Hyperactivity–Impulsivity–Irritiability–Disinhibition–Aggression–Agitation Domain in Alzheimer’s Disease: Current Management and Future Directions , 2019, Front. Pharmacol..

[32]  Mayur B. Patel,et al.  Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness , 2018, The New England journal of medicine.

[33]  Y. Karal,et al.  Viral etiological causes of febrile seizures for respiratory pathogens (EFES Study) , 2018, Human vaccines & immunotherapeutics.

[34]  James R. Johnson,et al.  Delirium in Hospitalized Older Adults. , 2018, The New England journal of medicine.

[35]  E. Marcantonio.  Delirium in Hospitalized Older Adults , 2017, The New England journal of medicine.

[36]  J. Rehm,et al.  The economic costs of mental disorders , 2016, EMBO reports.

[37]  B. Littlechild.  Violence and aggression: short-term management in mental health, health and community settings , 2015 .

[38]  Craig Newnes,et al.  Diagnostic and Statistical Manual , 2014, The SAGE Encyclopedia of Trans Studies.

[39]  G. Annoni,et al.  Validation of the 4AT, a new instrument for rapid delirium screening: a study in 234 hospitalised older people , 2014, Age and ageing.

[40]  Ian B Hogue,et al.  Virus infections in the nervous system. , 2013, Cell host & microbe.

[41]  K. Erlandson,et al.  Clinical pharmacokinetics of antiretroviral drugs in older persons , 2013, Expert opinion on drug metabolism & toxicology.

[42]  N. Bellei,et al.  Human coronavirus NL-63 infection in a Brazilian patient suspected of H1N1 2009 influenza infection: Description of a fatal case , 2011, Journal of Clinical Virology.

[43]  David K. Meyerholz,et al.  Severe Acute Respiratory Syndrome Coronavirus Infection Causes Neuronal Death in the Absence of Encephalitis in Mice Transgenic for Human ACE2 , 2008, Journal of Virology.

[44]  J. Peiris,et al.  Academic Editor: Sherif Zaki, Centers for Disease Control, United States of America , 2005 .

[45]  Theodore Speroff,et al.  Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. , 2004, JAMA.

[46]  R. Dessau,et al.  Coronaviruses in brain tissue from patients with multiple sclerosis , 2001, Acta Neuropathologica.

[47]  S. O’Keeffe,et al.  Clinical significance of delirium subtypes in older people. , 1999, Age and ageing.

[48]  H H MERRITT,et al.  Virus infections of the nervous system. , 1950, Bulletin of the New York Academy of Medicine.

[49]  Wen-chao Song,et al.  Complement and its role in innate and adaptive immune responses , 2010, Cell Research.

[50]  D. C. Henckel,et al.  Case report. , 1995, Journal.